Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-021451
Filing Date
2025-08-11
Accepted
2025-08-11 17:53:04
Documents
2
Period of Report
2025-08-08

Document Format Files

Seq Description Document Type Size
1 form4-08112025_090800.html 4  
1 form4-08112025_090800.xml 4 4580
2 ex24-08112025_090801.htm EX-24 4113
  Complete submission text file 0001415889-25-021451.txt   10073
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Issuer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064
Business Address
Boudreau Philip P (Reporting) CIK: 0001805099 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-02189 | Film No.: 251203275